European Cancer Organisation
login

Twitter tutorial

Twitter - the brief dialogue and content sharing point

 

Twitter is basically a large discussion forum of very short comments. You can either simply read and follow, or you can chose to participate yourself. In order to participate you need a profile. Every Twitter user has a profile. Here is ECCO's: @EuropeanCancer. (It's called a handle or a username.) Everybody in Twitter also has a profile page by default.

 

What you can do in Twitter:

  • Tweet: you can only use the infamous 140 characters in your message
  • In a tweet you can attach an image
  • Follow / unfollow people: If you like certain individuals or organisations you can follow them
  • Reply: If you want to reply privately to one person you have to use their @username
  • Whether you reply or tweet you can only use 140 characters in your message
  • Hashtags: In order to participate in specific debates/threads you can read and tweet with a #tag. E.g. #EBCC8. We recommend only using maximum 1-3 #tags per tweet
    Anybody can claim a #tag, invent it and use it. That is why ECCO's events' #tag sometime display tweets that have nothing to do with our event.
  • Retweet / favourite: you can forward what others tweet by retweeting or favouriting their tweets
  • Combine: you can combine a reply with a #tag in same tweet
  • Search for trends, topics and news: As Twitter is a great tool for live ongoing messaging you can always search for keywords that interest you and promptly interact with a topic

 

Twitter and ECCO

Twitter works great as an operational tool for events (ECCO uses it extensively). During events attendee tweets get integrated into the information flow, and ECCO engages in dialogue with users. Twitter is also a complementary channel for short messages on various specific updates.

Past events #tag
ECC2015 #ECC2015 
EACR-AACR-SIC 2015 #EAS2015
Films17 #Films17
EORTC-EANO-ESMO 2015 #EEE2015
EORTC-NCI-AACR 2014 #ENA2014
ESSO-34 #ESSO34
EONS-9  #EONS9
EACR23  #EACR23
Flims 16  #Flims16
ITOC1 #ITOC1
EBCC-9 #EBCC9
ECC 2013 #ECC2013
Oncopolicy Forum #oncopolicy

 

 

PRINT THIS PAGE Page last modified: